Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jan 5 2016

First Edition: January 5, 2016

Today's early morning highlights from the major news organizations.

Kaiser Health News: More Employers Offer Plans That Provide Lump Sums For Critical Illnesses

Insurance policies that pay a lump sum if workers get cancer or another serious illness are being offered in growing numbers by employers. Companies say they want to help protect their workers against the financial pain of increasingly high deductibles and other out-of-pocket costs. But it’s important to understand the limitations of these plans before buying. Critical illness plans have been around for decades, but they have become more common lately as employers have shifted more health care costs onto their workers' shoulders. (Andrews, 1/5)

Kaiser Health News: Cleveland Pressures Hospitals To Keep ERs Open To All Ambulances

The patient walks woozily out to the ambulance from a tan house on a tree-lined street. Anthony Savoy, the head medic, calls ahead to University Hospitals, which has the closest emergency room. Savoy wants to make sure the ER has space for the patient. The man gets in that day, but it was by no means guaranteed. For years, it’s been common practice for University Hospitals to switch its status to diversion. That means when Savoy would call the hospital, people in the emergency department would say they didn’t have the room or the staff to handle the patient. The EMS team then would have to drive to another hospital — often the Cleveland Clinic — about a mile away. (Tribble, 1/5)

The Associated Press: Medicare Is Changing: What’s New For Beneficiaries

Whether it's coverage for end-of-life counseling or an experimental payment scheme for common surgeries, Medicare in 2016 is undergoing some of the biggest changes in its 50 years. Grandma's Medicare usually just paid the bills as they came in. Today, the nation's flagship health-care program is seeking better ways to balance cost, quality and access. The effort could redefine the doctor-patient relationship, or it could end up a muddle of well-intentioned but unworkable government regulations. (Ricardo Alonso-Zaldivar, 1/4)

The Associated Press: Highlights Of Executive Actions Addressing Gun Violence

The Obama administration is announcing a series of executive steps aimed at curbing gun violence, including broader background checks and the hiring of additional specialists to process those checks. The White House is also proposing a $500 million investment to improve mental health care. (1/5)

The Wall Street Journal: Obama to Announce Expansion of Background Checks for Gun Purchases

President Barack Obama is directing administration officials to explore ways to expand the use of technology that can ensure a weapon can be fired only by its owner and proposed efforts to invest in mental-health care and include information in the background-check system about individuals who are prohibited from possessing a firearm for mental-health reasons. (Nelson and Fields, 1/5)

Politico: Doctors Can Report Some Mentally Ill Patients To FBI Under New Gun Control Rule

Delivering on its promise to deliver "common sense" gun control, the Obama administration on Monday finalized a rule that enables health care providers to report the names of mentally ill patients to an FBI firearms background check system. While the 1993 Brady law prohibits gun ownership by individuals who have been involuntarily committed, found incompetent to stand trial or otherwise deemed by a court to be a danger to themselves or others, federal health care privacy rules prohibited doctors and other providers from sharing information without the consent of their patients. Under the rule, which takes effect next month, for the first time health providers can disclose the information to the background check system without legal repercussions. (Pittman, 1/4)

The Wall Street Journal: Cadillac Tax Delay Gives CFOs Breathing Room

December’s omnibus budget package contained a measure to delay a provision of the Affordable Care Act by two years is giving finance chiefs some extra time to prepare. The tax on high-cost employee health plans puts employers on the hook for a 40% levy on any excess cost of health plans above certain thresholds. Even before the delay, many companies and municipalities had already begun to assess whether their plans would trigger additional payments and make preemptive changes to avoid it. (Murphy, 1/4)

The Associated Press: Democratic US Rep. Jim McDermott Announces Retirement

Longtime Democratic Rep. Jim McDermott of Washington state announced Monday that he will not seek re-election for a 15th time when he completes his term at the end of the year. McDermott said he was proud of the many things he has accomplished during his time in office, including reforms to foster care, affordable housing for people with AIDS, but most important, he said, was his work on the national health plan. (1/4)

The Washington Post's Fact Checker: Right To Rise Super PAC’s Series Of Misleading Claims About Jeb Bush’s Record

The new ad from a pro-Bush Super PAC touts Bush’s record as Florida’s governor, compared to the records of two other governors vying for the GOP nomination: Chris Christie and John Kasich. ... [The ad says Bush] "led the fight to stop Obamacare expansion in his state." Bush’s term as governor ended two years before President Obama took office, and three years before the Affordable Care Act was signed into law. So what exactly was Bush’s role? (Michelle Ye Hee Lee, 1/5)

The Wall Street Journal: Obama Administration Opposes Texas Abortion Restrictions

The Obama administration Monday urged the Supreme Court to strike down Texas abortion regulations it said effectively would eliminate access to the procedure for large numbers of women across the vast state. The high court is set to hear argument in March on a 2013 Texas law cracking down on abortion providers by requiring clinics offering the procedure to meet the standards of ambulatory surgical centers and doctors who perform it to hold admitting privileges at a hospital within 30 miles. (Bravin, 1/4)

The Washington Post: First-Of-A-Kind Drug Approvals Continued Rise In 2015

Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years. The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags. (Perrone, 1/4)

The Wall Street Journal: Gilead Gets FDA Priority Review Of Hepatitis C Combo Drug

Gilead Sciences Inc. said the U.S. Food and Drug Administration granted a priority review of its experimental hepatitis C combination drug. The Foster City, Calif., drugmaker filed a new drug application for the treatment—a combination of the biopharmaceutical company’s Sovaldi with velpatasvir—in late October. The FDA is expected to decide whether to approve the combination therapy by June 28. (Stynes, 1/4)

The Wall Street Journal: Heart Incidents End Parts Of Two Studies By Teva, Active Biotech

Teva Pharmaceutical Industries Ltd. and Active Biotech AB said Monday they were ending the higher-dose portions of two multiple-sclerosis studies with the drug Laquinimod after eight patients suffered nonfatal cardiovascular events. The companies said the incidents occurred in the higher-dose components of a phase 3 and a phase 2 clinical trial. The lower-dose and placebo components of the tests will continue. (Hufford, 1/4)

The Wall Street Journal: At The Hospital, Better Responses To Those Beeping Alarms

In hospitals, alarms on patient-monitoring devices create a cacophony of noise day and night—beeping, pinging and ringing so often that doctors and nurses ignore them, turn them off or just stop hearing them. Now, hospitals are adopting solutions to silence or eliminate unnecessary alarms, while ensuring that staffers don’t miss alerts that could signal a life-threatening crisis. Smarter technology and more-precise monitoring practices are helping prevent false alarms, alert nurses to true emergencies, and identify deteriorating patients before an alarm signals a crisis. (Landro, 1/4)

NPR: Veterans Say Trained Dogs Help With PTSD, But The VA Won't Pay

Service dogs are often trained to help veterans with physical disabilities. Now, a growing number are being trained to meet the demand from vets with post-traumatic stress disorder and other mental health issues. So far, though, the Department of Veterans Affairs won't help pay for service dogs for PTSD, citing a lack of scientific evidence. But it's launching a study to find out what effect specially trained service dogs can have on the lives of veterans with PTSD. (Silverman, 1/4)

The Wall Street Journal: New Weapons In The Fight Against Multiple Myeloma

Few types of cancer research have witnessed more progress in the past decade than the fight against the blood cancer known as multiple myeloma. There are 10 multiple myeloma treatments on the market, including three that won Food and Drug Administration approval during a remarkable 15-day span in November. Other medications in the pipeline hold promise to meet patients’ hopes for even further gains. (Winslow, 1/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 7
  • Monday, July 6
  • Thursday, July 2
  • Wednesday, July 1
  • Tuesday, June 30
  • Monday, June 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF